PlainRecalls
FDA Drug Low Class III Completed

Gildess FE 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fumarate tablets, USP 75 mg), 28 count, 6 blisters (NDC 0603-7609-17), Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST PHARMACEUTICALS, USA, Huntsville, AL 35811

Reported: November 9, 2016 Initiated: September 27, 2016 #D-0121-2017

Product Description

Gildess FE 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fumarate tablets, USP 75 mg), 28 count, 6 blisters (NDC 0603-7609-17), Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST PHARMACEUTICALS, USA, Huntsville, AL 35811

Reason for Recall

Subpotent Drug; Ethinyl Estradiol

Details

Recalling Firm
Par Pharmaceutical, Inc.
Units Affected
822,009 tablets
Distribution
Nationwide and Puerto Rico
Location
Chestnut Ridge, NY

Frequently Asked Questions

What product was recalled?
Gildess FE 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fumarate tablets, USP 75 mg), 28 count, 6 blisters (NDC 0603-7609-17), Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST PHARMACEUTICALS, USA, Huntsville, AL 35811. Recalled by Par Pharmaceutical, Inc.. Units affected: 822,009 tablets.
Why was this product recalled?
Subpotent Drug; Ethinyl Estradiol
Which agency issued this recall?
This recall was issued by the FDA Drug on November 9, 2016. Severity: Low. Recall number: D-0121-2017.